Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

NCT02274740 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision not related to safety reasons

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: LIXISENATIDE AVE0010
DRUG: metformin

Sponsor

Sanofi